Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other Non-Current Assets (2019 - 2025)

Biodesix (BDSX) has disclosed Other Non-Current Assets for 7 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 13.36% year-over-year to $8.2 million, compared with a TTM value of $8.2 million through Dec 2025, up 13.36%, and an annual FY2025 reading of $8.2 million, up 13.36% over the prior year.
  • Other Non-Current Assets was $8.2 million for Q4 2025 at Biodesix, up from $7.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $8.2 million in Q4 2025 and bottomed at $1.7 million in Q4 2021.
  • Average Other Non-Current Assets over 5 years is $5.6 million, with a median of $6.5 million recorded in 2023.
  • Peak annual rise in Other Non-Current Assets hit 2107.37% in 2021, while the deepest fall reached 52.12% in 2021.
  • Year by year, Other Non-Current Assets stood at $1.7 million in 2021, then soared by 257.45% to $5.9 million in 2022, then grew by 15.8% to $6.9 million in 2023, then increased by 5.85% to $7.3 million in 2024, then rose by 13.36% to $8.2 million in 2025.
  • Business Quant data shows Other Non-Current Assets for BDSX at $8.2 million in Q4 2025, $7.5 million in Q3 2025, and $7.2 million in Q2 2025.